Article
Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma.
Endocrine-related cancer - 1 Jul 2017
Plantinga Theo S, Petrulea Mirela S, Oosting Marije, Joosten Leo A B, Piciu Doina, Smit Johannes W, Netea-Maier Romana T, Georgescu Carmen E
Abstract excerpt
The NF-κB inflammatory pathway plays a major role in cancer development and clinical progression. Activation of NF-κB signaling is promoted by NFKB1 and inhibited by NFKBIA. The present study aimed to determine the relevance of NFKB1 rs4648068 and NFKBIA rs2233406 genetic variants for non-medullary thyroid cancer (NMTC) susceptibility, progression and clinical outcome. This case-control and cohort study consists...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
